Spectrum Pharmaceuticals, Inc. (SPPI) Misses Q4 EPS by 7c, Sales Fall Inline

Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) reported Q4 non-GAAP EPS of $0.24, $0.07 worse than the analyst estimate of $0.31. Revenue for the quarter came in at $5.98 million versus the consensus estimate of $52.73 million.

For earnings history and earnings-related data on Spectrum Pharmaceuticals, Inc. (SPPI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• XP Inc eyes US banking license as next business step
• Wendy's U.S. president to resign, company to create COO role